LYNBROOK, N.Y., Nov. 6 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. , a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter...
[read full story]
powered by 